Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC), expected in Q1...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.3733 | -16.5457831325 | 8.3 | 8.765 | 6.905 | 1303371 | 8.13672576 | CS |
4 | 0.1967 | 2.92273402675 | 6.73 | 10.38 | 6.13 | 2593572 | 8.77308828 | CS |
12 | 1.2467 | 21.948943662 | 5.68 | 14.6 | 3.785 | 3929698 | 7.81369836 | CS |
26 | 0.7267 | 11.7209677419 | 6.2 | 14.6 | 3.785 | 1899990 | 7.70091294 | CS |
52 | 5.6267 | 432.823076923 | 1.3 | 14.6 | 1.16 | 2451389 | 7.12401164 | CS |
156 | 0.4267 | 6.56461538462 | 6.5 | 14.6 | 0.66 | 882100 | 6.71418228 | CS |
260 | -1.0733 | -13.41625 | 8 | 14.78 | 0.66 | 773613 | 6.75061855 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.